What is the recommended approach to evaluating and managing dysmenorrhea?

Approach to Dysmenorrhea

Start with NSAIDs as first-line therapy for dysmenorrhea, and add hormonal contraceptives if NSAIDs alone are insufficient or if contraception is desired. 1, 2

Initial Clinical Assessment

Obtain a focused menstrual history and pregnancy test for sexually active patients 1:

• Primary dysmenorrhea: Cramping pain limited to menses, starting with or just before menstrual flow, lasting 1-3 days, with normal pelvic examination 2, 3
• Secondary dysmenorrhea: Progressive worsening pain, abnormal uterine bleeding, vaginal discharge, dyspareunia, noncyclic pain, or abnormal pelvic findings warrant further investigation 1, 4

Key distinction: Primary dysmenorrhea occurs in the absence of pelvic pathology and is caused by prostaglandin-mediated uterine hypercontractility 2, 3. Secondary dysmenorrhea requires identification of underlying pathology such as endometriosis or adenomyosis 5, 4.

First-Line Pharmacologic Treatment

NSAIDs (Preferred Initial Therapy)

NSAIDs are the most effective first-line treatment by blocking prostaglandin synthesis through cyclooxygenase inhibition 1, 2, 6:

• Start NSAIDs at onset of menses or just before, continue for 5-7 days 5
• Options include ibuprofen, mefenamic acid, or celecoxib 5
• Critical timing: NSAIDs work best when started before pain becomes severe 2

Hormonal Contraceptives (First-Line Alternative or Addition)

Hormonal contraceptives are equally effective as NSAIDs and should be prioritized when contraception is desired 1, 2:

• Combined hormonal contraceptives (CHCs), progestin-only pills, or levonorgestrel-releasing IUD all reduce dysmenorrhea 5
• Extended or continuous CHC regimens reduce menstrual frequency and associated pain 5
• For adenomyosis specifically, dienogest or levonorgestrel-releasing IUD are effective options 7, 8

Combination therapy: NSAIDs plus hormonal contraceptives can be used together for enhanced efficacy 1, 2

Evidence-Based Non-Pharmacologic Options

The following have strong evidence and can be used alone or with pharmacologic therapy 1, 4:

• Heat therapy: Topical heat application provides significant pain relief 1, 6, 4
• Physical exercise: Regular aerobic exercise reduces dysmenorrhea severity 1, 6, 3
• Transcutaneous electrical nerve stimulation (TENS): Effective for pain reduction 1, 6

When to Suspect Secondary Dysmenorrhea

Perform pelvic examination and transvaginal ultrasonography if 1, 4:

• Pain progressively worsens over time
• Dyspareunia or noncyclic pelvic pain present
• Abnormal uterine bleeding or vaginal discharge
• No improvement after 3 months of compliant first-line therapy 2
• Abnormal pelvic examination findings

Endometriosis is the most common cause of secondary dysmenorrhea 5, 4. Adenomyosis presents with dysmenorrhea, menorrhagia, and uniformly enlarged uterus 4.

Management Algorithm for Secondary Dysmenorrhea

For Endometriosis

Hormonal contraceptives are first-line treatment for endometriosis-related dysmenorrhea 5, 4:

• Oral contraceptives, progestins, or GnRH agonists all reduce lesion size and pain 5
• GnRH agonists for ≥3 months or danazol for ≥6 months provide equal pain relief 5
• Add-back therapy with GnRH agonists prevents bone loss without reducing efficacy 5
• Surgery provides significant pain reduction for 6 months, but 44% experience recurrence within 1 year 5

For Adenomyosis

Treatment options include 7, 8:

• Dienogest 2 mg daily
• Levonorgestrel-releasing IUD (including hysteroscopic fixation for severe cases)
• Uterine artery embolization achieves superior symptom relief compared to dienogest at 6 months (93.3% vs 66.7% complete resolution of chronic pelvic pain) 7

Treatment Failure Protocol

If symptoms persist despite 3 months of compliant NSAID and/or hormonal therapy 2, 3:

1. Initiate evaluation for secondary dysmenorrhea with pelvic examination and transvaginal ultrasonography 1, 4
2. Consider referral to gynecology for further evaluation 1, 4
3. Advanced imaging (MRI) may be needed for suspected deep endometriosis or adenomyosis 5

Common Pitfalls to Avoid

• Do not delay empiric treatment: Women with typical primary dysmenorrhea history can start NSAIDs and/or hormonal contraceptives without additional testing 2, 3
• Do not undertreat: Dysmenorrhea affects 50-90% of reproductive-age women and is a leading cause of absenteeism; it requires aggressive management 1, 9
• Do not assume all dysmenorrhea is primary: Progressive worsening, abnormal bleeding, or treatment failure mandates evaluation for secondary causes 1, 4
• Do not forget timing: NSAIDs must be started at or before pain onset for maximum efficacy 2